Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.

Journal of the American Society of Nephrology : JASN - 1 May 2002

Skoupy Sonja, Födinger Manuela, Veitl Mario, Perschl Agnes, Puttinger Heidi, Röhrer Claudia, Schindler Karin, Vychytil Andreas, Hörl Walter H, Sunder-Plassmann Gere

Abstract excerpt

The effect of thiamine (vitamin B(1)) or riboflavin (vitamin B(2)) availability on fasting total homocysteine (tHcy) plasma levels in end-stage renal disease patients is unknown. A cross-sectional study was performed in a population of non-vitamin supplemented patients maintained on continuous ambulatory peritoneal dialysis. Red blood cell availability of thiamine (alpha-ETK) and of riboflavin (alpha-EGR), along...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Homocysteine

Share to Kidney Failure, Chronic

Share to Logistic Models

Share to Riboflavin

Share to Thiamine

Source

Identifiers

PMID: 11961021
DOI: 10.1097/01.asn.0000013299.11876.f6

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.PMID 11961021Read ↗

Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.Semantic proximity Read ↗

Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.Semantic proximity Read ↗

B-vitamins, homocysteine metabolism and CVD.Semantic proximity Read ↗

Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.Semantic proximity Read ↗

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.Semantic proximity Read ↗

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.Semantic proximity Read ↗

Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genotype predict plasma homocysteine in folate-deplete Mexican-American men with the methylenetetrahydrofolate reductase 677TT genotype.Semantic proximity Read ↗

Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.Semantic proximity Read ↗

Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.Semantic proximity Read ↗

Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition.Semantic proximity Read ↗

Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.